About Cochrane

Cochrane is an international not-for-profit and independent organisation, dedicated to making up-to-date, accurate information about the effects of healthcare readily available worldwide. It produces and disseminates systematic reviews of healthcare interventions and promotes the search for evidence in the form of clinical trials and other studies of interventions.

Cochrane was founded in 1993 and named after the British epidemiologist, Archie Cochrane. The major product of Cochrane is the Cochrane Database of Systematic Reviews which is published quarterly as part of Cochrane Library.

Those who prepare the reviews are mostly health care professionals who volunteer to work in one of the many Cochrane Review Groups, with editorial teams overseeing the preparation and maintenance of the reviews, as well as application of the rigorous quality standards for which Cochrane Reviews have become known.

The activities of Cochrane are directed by an elected Steering Group and are supported by staff in Cochrane Entities (Centres, Review Groups, Methods Groups, Fields/Networks) around the world.


Introducing Cochrane's new CEO

Dear Colleagues,
I am thrilled to have started in post as Cochrane’s new Chief Executive Officer and look forward to working with you all. It was a pleasure to meet many of you at the Colloquium in Auckland in October, and thank you for the warm welcome I received there. It was a memorable introduction to the Collaboration and I extend my thanks to the New Zealand Branch for their tremendous organisation of the event.
I would like to take this opportunity to thank Paul Farenden, the outgoing Interim Executive Director, who has managed operations since Nick Royle’s departure earlier in the year. Particular thanks must also go to David Tovey, Editor in Chief of The Cochrane Library, who took on very heavy additional tasks during this interim period; and to Jonathan Craig and Jeremy Grimshaw, Co-Chairs of Cochrane’s Steering Group, who shouldered many additional burdens.
My task for the coming weeks and months is to continue what I began in Auckland: to get to know you and the organization; to listen, to evaluate and plan; and then to begin implementing change. I’ve already begun working closely with the Steering Group and the Co-Chairs, who have been enormously supportive of my initial ideas; and it’s a privilege to be joining and leading so many talented, professional staff within the Operations and Editorial Units and the Web and IMS teams.
As I said after my appointment, my mission is to build on Cochrane’s dynamic growth over nearly two decades and expand its influence and impact in future. This will be achieved, in large part, by strengthening the organisation’s central infrastructure which supports you, the people behind Cochrane’s unique vision and amazing success.
Best wishes,
Mark G. Wilson
Chief Executive Officer